| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/12/2006 | CN1759109A Substituted benzoylureidopyridyl-piperidine and -pyrrolidinecarboxylic acid derivatives, method for the production thereof and the use thereof |
| 04/12/2006 | CN1759108A Biphenyl derivatives |
| 04/12/2006 | CN1759101A Quinolinone / benzoxazinone derivatives and uses thereof |
| 04/12/2006 | CN1759097A Chemical process for the preparation of intermediates to obtain N-formyl hydroxylamine compounds |
| 04/12/2006 | CN1250540C Improved single-reactor synthesis of [2,8-di(trifluoromethyl)-4-quinolyl]-2-pyridyl methyl ketone and methylfluoro quine |
| 04/12/2006 | CN1250539C Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound |
| 04/12/2006 | CN1250533C Novel azoles having an insecticidal action |
| 04/12/2006 | CN1250531C Novel compounds |
| 04/12/2006 | CN1250218C Use of angiotensin II antagonists |
| 04/12/2006 | CN1250192C 2, 5-diaminopyridine oxidation color display alkali for dyeing keratin fiber |
| 04/12/2006 | CA2484473A1 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea salt |
| 04/11/2006 | US7026498 Coordination catalyst containing ligand |
| 04/11/2006 | US7026486 Process for production cilostazol |
| 04/11/2006 | US7026485 inhibitors of HIV protease; N-heterocyclic moiety containing hydroxyethylamine compounds where the heterocyclic moiety may be octahydroisoquinoline |
| 04/11/2006 | US7026482 Process for preparing imidazoquinolinamines |
| 04/11/2006 | US7026479 Process for the production of quinazolines |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026357 Diphenylurea compounds |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026346 Anticancer agents |
| 04/11/2006 | US7026336 4-pyridinylimidazol-2-ylhydrocarbyl amine, (thio)urea, carbamic acid or sulfonamide derivatives, e.g., (2-(4-(4-Chloro-3-methoxy-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl)-2-methyl-propyl)-carbamic acid tert-butyl ester; Raf kinase inhibitors for the treatment of neurotraumatic diseases |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |
| 04/11/2006 | US7026333 Retroviral protease inhibitors |
| 04/11/2006 | US7026328 Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins |
| 04/11/2006 | US7026327 2-etherified 4-fluoroalkyl-6-(p-sulfonylphenyl)pyrimidines,e.g., 2-(4-fluorophenoxy)-4-[4-(methylsulfonyl)phenyl]-6](trifluoromethyl)pyrimidine; treatment of the pain, fever and inflammation of variety of conditions and diseases |
| 04/11/2006 | US7026326 Substituted heterocyclic compounds and methods of use |
| 04/11/2006 | US7026324 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 04/11/2006 | US7026323 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 04/11/2006 | US7026314 Psychological disorders, antidepressants, anxiolytic agents, eating disorders; serotonin receptors antagonist |
| 04/11/2006 | US7026312 Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 04/11/2006 | US7026310 Heteroaryl derivatives and their use as medicaments |
| 04/11/2006 | US7026270 malayamycin A and desmethylmalayamycin A prepared from a previously unknown strain of Streptomyces malaysiensis, used for combating or controlling phytopathogenic fungi |
| 04/11/2006 | US7025978 Use of polysiloxanes containing quarternary amino groups as formulation auxiliary agents, and agents containing the same |
| 04/11/2006 | CA2274530C Process for producing 5-arylthio imidazole derivatives |
| 04/11/2006 | CA2181570C Metalloproteinase inhibitors |
| 04/11/2006 | CA2162382C Intercalators having affinity for dna and methods of use |
| 04/06/2006 | WO2006037117A1 Substituted heterocyclic compounds and methods of use |
| 04/06/2006 | WO2006037047A2 The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents |
| 04/06/2006 | WO2006036994A2 Modulators of crth2, cox-2 and faah |
| 04/06/2006 | WO2006036981A2 Small molecule modulators of cytokine activity |
| 04/06/2006 | WO2006036936A2 The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents |
| 04/06/2006 | WO2006036527A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | WO2006036507A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036497A2 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036404A1 4-(substituted cycloalkylmethyl) imidazole-2-thones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cyloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 04/06/2006 | WO2006036024A1 Proton pump inhibitors |
| 04/06/2006 | WO2006036015A2 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 04/06/2006 | WO2006035967A1 Pyridine derivatives and their use as medicaments for treating diseases related to mch receptor |
| 04/06/2006 | WO2006035303A1 Muscarinic receptor antagonists |
| 04/06/2006 | WO2006035280A1 3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases |
| 04/06/2006 | WO2006035068A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/06/2006 | WO2006035067A2 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | WO2006034833A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | WO2006034769A1 Carbonyl compounds usable as coagulation factor xa inhibitors |
| 04/06/2006 | WO2006023460A3 COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 04/06/2006 | WO2005081687A3 Human hinge core mimetibodies, compositions, methods and uses |
| 04/06/2006 | WO2005065195A3 Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/06/2006 | WO2005023796A8 New salts of omeprazole and esomeprazole i |
| 04/06/2006 | US20060074247 Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074243 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 04/06/2006 | US20060074241 Enantioselective process |
| 04/06/2006 | US20060074240 Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline |
| 04/06/2006 | US20060074237 Pyridines |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074120 cyclopent[f]pyrazole derivatives; antiinflammatory agent; autoimmune diseases; side effect reduction, advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity or metabolism |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | US20060074106 Treatment of inflammatory disorders |
| 04/06/2006 | US20060074105 Substituted quinoline and quinazoline inhibitors of quinone reductase 2 |
| 04/06/2006 | US20060074092 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases |
| 04/06/2006 | US20060074085 Bcl-XL inhibitors; N-{[4-({(1R)-5-(dimethylamino)-1-[(phenylthio)methyl]pentyl}amino)-3-nitrophenyl]sulfonyl}-4-(4-fluorophenyl)piperidine-1-carboxamide; useful for promoting apoptosis; Anticancer agents; autoimmune diseases; antiinflammatory agents |
| 04/06/2006 | US20060074075 including cystic fibrosis transmembrane conductance regulator ("CFTR"), used for treating genetic disorders; respiratory system disorders |
| 04/06/2006 | US20060074072 2-[3-(4-chlorophenyl)ureido] N-[4-(2-oxo-2H-pyridin-1-yl)phenyl]-4-methanesulfonylbutyramide; prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors |
| 04/06/2006 | US20060074069 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders |
| 04/06/2006 | US20060074068 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 04/06/2006 | US20060073472 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 04/06/2006 | DE102004047272A1 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
| 04/06/2006 | DE102004044829A1 5-Heterocyclylpyrimidine 5-Heterocyclylpyrimidine |
| 04/06/2006 | CA2582777A1 Proton pump inhibitors |
| 04/06/2006 | CA2582225A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | CA2581828A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581823A1 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581732A1 Carbonyl compounds usable as coagulation factor xa inhibitors |
| 04/06/2006 | CA2581179A1 6-(pyridinyl)-4 pyrimidone derivatives as tau protein kinase 1 inhibitors |
| 04/06/2006 | CA2580838A1 Substituted heterocyclic compounds and methods of use |
| 04/06/2006 | CA2579240A1 Small molecule modulators of cytokine activity |
| 04/06/2006 | CA2577467A1 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | CA2577185A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | CA2573976A1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/05/2006 | EP1642899A1 2,4-bis(trifluoroethoxy)pyridine compound and medicine containing the same |
| 04/05/2006 | EP1641780A1 Processes for the preparation of 1- [(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 04/05/2006 | EP1641779A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 04/05/2006 | EP1641778A1 Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines |
| 04/05/2006 | EP1641777A1 Indole derivatives with apoptosis-inducing effect |
| 04/05/2006 | EP1641776A1 Novel piperidine derivatives |
| 04/05/2006 | EP1641775A1 2-pyridine alkyne derivatives useful for treating pain |
| 04/05/2006 | EP1641765A1 Aryl-heteroaromatic products, compositions containing same and use thereof |
| 04/05/2006 | EP1641764A1 5-membered heterocycle-based p38 kinase inhibitors |
| 04/05/2006 | EP1641763A2 4-cyanopyrazole-3-carboxamide derivatives preparation and therapeutic application thereof |
| 04/05/2006 | EP1641762A2 Cck-1 receptor modulators |